Dermatomyositis and acute interstitial lung disease associated with MDA-5 antibodies: An atypical case

被引:13
|
作者
Girard, C. [1 ]
Vincent, T. [2 ]
Bessis, D. [1 ]
机构
[1] Univ Montpellier I, CHU, Hop St Eloi, Dept Dermatol, F-34295 Montpellier 5, France
[2] Univ Montpellier I, CHU, Hop St Eloi, Immunol Lab, F-34295 Montpellier 5, France
来源
关键词
Dermatomyositis; MDA-5; antibodies; Interstitial lung disease; Acquired ichthyosis; JAPANESE PATIENTS; GENE; 5; JUVENILE DERMATOMYOSITIS; INFLAMMATORY MYOPATHIES; AUTOANTIBODIES; CALCINOSIS; ANTI-MDA5; CADM-140; FEATURES; PROTEIN;
D O I
10.1016/j.annder.2013.04.083
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background. - A new antibody known as anti-MDA-5 has recently been identified in association with a specific phenotype of dermatomyositis (DM), in which muscular involvement is minimal or absent, but where there is a particularly high risk of onset of aggressive interstitial lung disease. Below, we report a case associated with the presence of anti-MDA-5 antibodies complicated by aggressive interstitial lung disease; the cutaneous phenotype of this patient is novel due to the constitution of diffuse ichthyosis and of profuse subcutaneous calcinosis. Patients and methods. - A 35-year-old man was hospitalised for a skin rash associated with arthralgia, dry cough, asthenia and weight-loss of 8 kg in 5 months. The dermatological examination revealed purple erythema of the upper eyelids and cheeks, diffuse acquired ichthyosis of the trunk and limbs, and striated erythema on the proximal and distal metacarpal and interphalangeal joints of the fingers. A diagnosis of DM was suspected in patients treated with prednisolone, 1.5 mg/kg/d. Immunological tests identified the presence of anti-MDA-5 antibodies. One month later, the cutaneous signs continued to progress and were marked by the development of painful ulcers on the back of the fingers, as well as dyspnoea accompanying the slightest effort. Chest images showed constituted pulmonary fibrosis lesions. At the same time, within several months, diffuse, pseudo-tumoural calcifications developed in the subcutaneous tissue of the trunk and limbs. The patient was treated successively with intravenous gammaglobulins, cyclophosphamide, mycophenolate mofetil, azathioprine and rituximab in combination with oral corticosteroids, but with no improvement in respiratory function or in the skin lesions. Because of the decline in the patient's respiratory status, a lung graft was envisaged but subsequently abandoned because of the patient's excessively precarious state of health. Discussion. - Anti-MDA-5 antibody appears to constitute a specific immunological marker for a special dermatological phenotype of adult DM, significantly associated with the presence of: 1) keratotic papules in the skin folds of the palms and fingers; 2) cutaneous ulcers along the periungueal edges, Gottron's papules on the back of the hands and on the extensor surface of the elbows and knees; 3) pain and ulceration in the oral mucosa, diffuse alopecia, and appearance of "mechanic's hands" and Gottron's sign on the elbows and knees. To our knowledge, the presence of extensive ichthyosis and profuse subcutaneous calcinosis has not been previously reported in this particular form of DM. The risk of aggressive interstitial lung disease is particularly high and worsens the prognosis, since 40% of patients with anti-MDA-5 die, usually within the first year. Conclusion. Herein, we describe a patient presenting amyopathic DM complicated by aggressive interstitial lung disease associated with the presence of anti-MDA-5 antibodies, but with a hitherto unreported cutaneous phenotype combining diffuse ichthyosis and profuse subcutaneous calcinosis. (C) 2013 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:628 / 634
页数:7
相关论文
共 50 条
  • [21] PROGRESSIVE INTERSTITIAL LUNG DISEASE ASSOCIATED WITH ANTI-MDA5 POSITIVE DERMATOMYOSITIS
    Vahabzadeh, Arshia
    Ventimiglia, William A.
    CHEST, 2023, 164 (04) : 3217A - 3217A
  • [22] Early recognition and management of MDA-5 associated juvenile dermatomyositis
    Gutierrez, Hernandez A. Y.
    Chan, G.
    Crew, A.
    Luu, M.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2025, 73 (01) : 44 - 45
  • [24] High-Emergency Lung Transplantation for Interstitial Lung Disease Associated With Anti-MDA5 Dermatomyositis: A Case Report
    Marchiset, Antoine
    Neuville, Mathilde
    Voiriot, Guillaume
    De Wolf, Julien
    Glorion, Matthieu
    Parquin, Francois
    Roux, Antoine
    Le Guen, Morgan
    Allenbach, Yves
    Zuber, Benjamin
    Cerf, Charles
    TRANSPLANTATION PROCEEDINGS, 2021, 53 (08) : 2613 - 2615
  • [25] Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis
    Wanlong Wu
    Li Guo
    Yakai Fu
    Kaiwen Wang
    Danting Zhang
    Wenwen Xu
    Zhiwei Chen
    Shuang Ye
    Clinical Reviews in Allergy & Immunology, 2021, 60 : 293 - 304
  • [26] Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis
    Wu, Wanlong
    Guo, Li
    Fu, Yakai
    Wang, Kaiwen
    Zhang, Danting
    Xu, Wenwen
    Chen, Zhiwei
    Ye, Shuang
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2021, 60 (02) : 293 - 304
  • [27] Fast-Onset Diffuse Interstitial Lung Disease in Anti-MDA5 Antibodies-Associated Amyopathic Dermatomyositis
    Aissaoui, Houari
    Alsibai, Kinan Drak
    Khayath, Naji
    CLINICS AND PRACTICE, 2021, 11 (02) : 235 - 240
  • [28] Rituximab for Rapidly Progressive MDA5 Dermatomyositis-Associated Interstitial Lung Disease
    Mak, J.
    Gandhi, R.
    Zaidan, M. F.
    Murthy, V.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [29] Interstitial lung disease-associated with amyopathic dermatomyositis and anti-MDA5 autoantibodies
    Gerfaud-Valentin, M.
    Ahmad, K.
    Piegay, F.
    Fabien, N.
    Raphanel, B.
    Cordier, J. -F.
    Cottin, V.
    REVUE DES MALADIES RESPIRATOIRES, 2014, 31 (09) : 849 - 853
  • [30] Prognostic analysis of MDA5-associated clinically amyopathic dermatomyositis with interstitial lung disease
    Wang, Wen
    Sun, Xiang
    Xu, Yan
    Tan, Wenfeng
    Liu, Ye
    Zhou, Jun
    IMMUNITY INFLAMMATION AND DISEASE, 2024, 12 (06)